$OTIC

Otonomy Inc

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$2.17 ▲2.871%

Last Close

VOLUME

44,878

DAY RANGE

2.06 - 2.2

52 WEEK

1.14 - 2.59

Key Metrics

Market Cap

122.38 M

Beta

0

Avg. Volume

166.35 K

Shares Outstanding

56.92 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-04

Next Dividend Date

Company Information

Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière's disease, hearing loss, and tinnitus.

CEO: David Weber

Website:

HQ: 4796 Executive Dr San Diego, 92121-3090 California

Related News